Publications

Journal Article Ppublish

PubMed: 40331369 DOI: 10.1080/13880209.2025.2498166

Tanshinone IIA reduces tubulointerstitial fibrosis by suppressing GSDMD-mediated pyroptosis.

Pharm Biol 63(1):364-373

Authors: Xueling Yang, Qinglin Luo, Zhifen Wu, Chunxuan Wang, Yuanjing Yang, Luquan Zheng, Ke Li, Lei Zhao, Yang Jurong

Affiliations

  • Department of Nephrology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Core Research Laboratory, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.

Abstract

CONTEXT

Tanshinone IIA (Tan IIA), a bioactive compound derived from the traditional Chinese herb , is well-known for its protective effects in various kidney diseases. However, its role in obstructive nephropathy has not been thoroughly investigated.

OBJECTIVE

This study aimed to explore the protective effects of Tan IIA in a mouse model of unilateral ureteral obstruction (UUO) and to elucidate the cellular and molecular mechanisms underlying these effects.

MATERIALS AND METHODS

Gasdermin D (GSDMD) knockout mice and their wild-type (WT) littermates underwent UUO surgery, with Tan IIA treatment administered 24 h prior. Human proximal tubular cells (HK-2 cells) were treated with TGF-β1 to induce fibrosis (50 ng/mL for 24 h), followed by Tan IIA treatment (5 μM) for an additional 3 h.

RESULTS

Tan IIA significantly reduced the expression of extracellular matrix (ECM) components, including collagen I, α-smooth muscle actin (α-SMA), vimentin and fibronectin, in UUO mice. Tan IIA attenuated GSDMD-mediated pyroptosis. However, in GSDMD knockout mice subjected to UUO, the protective effects of Tan IIA on ECM gene expression and collagen deposition in the tubular interstitium were reduced. studies showed that Tan IIA reduced GSDMD activation and fibronectin protein expression in HK-2 cells.

DISCUSSION AND CONCLUSIONS

Tan IIA may mitigate GSDMD-mediated pyroptosis in renal tubular epithelial cells (RTECs) and reduce kidney fibrosis, highlighting its potential as a therapeutic strategy to prevent the progression of kidney disease after ureteral obstruction.

MeSH

Kidney Diseases, Cells, Fibrosis, Collagen, Kidney, Ureteral Obstruction, Pyroptosis, Therapeutics, Fibronectins, Cell Death